The allergic rhinitis global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Allergic Rhinitis Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The allergic rhinitis market size has grown steadily in recent years. It will grow from $14.57 billion in 2023 to $15.22 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to allergen exposure, environmental changes, public awareness, incresing pollution, research and developments on allergic rhinitis, rising disposable incomes.
The allergic rhinitis market size is expected to see steady growth in the next few years. It will grow to $17.62 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to demand for preventive treatments, aging population, urbanization, health care spending. Major trends in the forecast period include biologics and monoclonal antibodies, digital health solutions, allergen avoidance strategies, pediatric allergic rhinitis, allergen detection technology.
Order your report now for swift delivery @
Scope Of Allergic Rhinitis Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Allergic Rhinitis Market Overview
Market Drivers –
High levels of air pollution and climate change are expected to propel the growth of the allergic rhinitis market going forward. Air pollution refers to the presence of harmful substances in the Earth’s atmosphere that can adversely affect human health, the environment and the quality of the air we breathe. Climate change refers to long-term alterations in the Earth’s climate patterns, including temperature, precipitation and other climatic factors. Air pollution has been increasingly recognized as a significant environmental factor contributing to the prevalence and worsening of allergic rhinitis, highlighting the intricate relationship between air quality and respiratory health. For instance, in September 2022, according to the World Bank, a US-based financial institution, it was estimated that the cost of the health damage caused by air pollution would amount to $8.1 trillion a year, equivalent to 6.1% of global GDP. Therefore, high levels of air pollution and climate change drive the allergic rhinitis market.
Market Trends –
Major companies operating in the allergic rhinitis market are developing innovative medications to sustain their position in the market. For instance, in August 2022, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company and Glenmark Specialty S.A., a Switzerland-based pharmaceutical company, unveiled approval for their product Ryaltris by the United States Food and Drug Administration (FDA), a US-based federal agency. Ryaltris is the first fixed-dose combination drug that treats nasal and ocular symptoms of seasonal allergic rhinitis in a convenient nasal spray for adult and pediatric patients 12 years of age and older. Within 15 minutes of taking the first dose, the relief of nasal symptoms starts to take effect.
The allergic rhinitis market covered in this report is segmented –
1) By Type: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis
2) By Treatment: Antihistamines; Corticosteroids; Immunotherapy; Decongestants; Other Treatments
3) By Test: Skin Test; IgE Radioallergosorbent (RAST) Test; Complete Blood Count
4) By Route Of Administration: Oral; Nasal; Other Route Of Administration
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores
Get an inside scoop of the allergic rhinitis market, Request now for Sample Report @
Regional Insights –
North America was the largest region in the allergic rhinitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major players in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.
Table of Contents
1. Executive Summary
2. Allergic Rhinitis Market Report Structure
3. Allergic Rhinitis Market Trends And Strategies
4. Allergic Rhinitis Market – Macro Economic Scenario
5. Allergic Rhinitis Market Size And Growth
…..
27. Allergic Rhinitis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Twitter: https://twitter.com/tbrc_info
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
